Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA/ FR0013154002 /
DIM
03/06/2024 17:35:09
|
Diferencia
-1.10
|
Volumen |
Bid7:30:05 |
Ask3:01:07 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
181.55EUR
|
-0.60%
|
62,448 Volumen de negocios: 11.27 millones |
180.05Volumen de oferta: 1 |
182.00Tamaño/ Volumen/ Formato de Ask: 100 |
16.74 mil millonesEUR |
0.38% |
54.03 |
Descripción de negocio
Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.
Consejo de gestión & Consejo de supervisión
CEO |
Dr. Joachim Kreuzburg |
Consejo de gestión |
Alexandra Gatzemeyer, Dr. René Fáber |
Consejo de supervisión |
Joachim Kreuzburg, René Fáber, Pascale Boissel, Susan Dexter, Romaine Fernandes, Anne-Marie Graffin, Lothar Kappich, Henri Riey |
Calendario de la empresa
CW 29 | 19/07/2024
Interim Report 2nd Quarter/6 Months
|
CW 42 | 17/10/2024
Interim Report 3rd Quarter/9 Months
|